About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Glul
glutamate-ammonia ligase
MGI:95739
36 phenotypes from 5 alleles in 7 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Glultm1.1Geno/Glultm1.1Geno
B6J.Cg-Glultm1.1Geno
no abnormal phenotype detected J:221031
Glultm1.1Geno/Glultm1.1Geno
Speer6-ps1Tg(Alb-cre)21Mgn/Speer6-ps1+
involves: C57BL/6 * C57BL/6J * DBA
abnormal fear-related response J:221031
normal homeostasis/metabolism phenotype J:221031
hyperactivity J:221031
increased circulating ammonia level J:221031
normal liver/biliary system phenotype J:221031
oxidative stress J:221031
premature death J:221031
Glultm1.1Ncd/Glultm1.1Ncd
Emx1tm1(cre)Krj/Emx1+
B6.Cg-Glultm1.1Ncd Emx1tm1(cre)Krj
abnormal blood vessel physiology J:272643
abnormal brain vasculature morphology J:272643
abnormal locomotor activation J:272643
astrocytosis J:272643
decreased anxiety-related response J:272643
decreased aspartic acid level J:272643
decreased gamma-aminobutyric acid level J:272643
decreased glutamic acid level J:272643
decreased glutamine level J:272643
decreased locomotor activity J:272643
decreased vertical activity J:272643
hippocampus pyramidal cell degeneration J:272643
increased locomotor activity J:272643
neurodegeneration J:272643
premature death J:272643
seizures J:272643
Glultm1Whla/Glultm1Whla
FVBHanHsd.129P2-Glultm1Whla
embryonic lethality before implantation, incomplete penetrance J:122377
embryonic lethality, complete penetrance J:122377
Glultm1Whla/Glultm2Whla
involves: 129P2/OlaHsd
embryonic lethality between somite formation and embryo turning, complete penetrance J:122377
Glultm3Whla/Glultm1Whla
Tg(Ckmm-cre)5Khn/0
involves: 129P2/OlaHsd * FVB
abnormal amino acid level J:161082
abnormal ammonia homeostasis J:161082
abnormal postnatal growth J:161082
decreased circulating glutamine level J:161082
decreased glutamine level J:161082
Glultm3Whla/Glultm1Whla
Tg(GFAP-cre)25Mes/0
involves: 129P2/OlaHsd * FVB/N
abnormal amino acid level J:162067
abnormal ammonia homeostasis J:162067
abnormal brain morphology J:162067
abnormal food intake J:162067
decreased circulating glucose level J:162067
decreased glutamine level J:162067
increased glycine level J:162067
postnatal lethality, complete penetrance J:162067
Glultm3Whla/Glultm3Whla
Tg(Ckmm-cre)5Khn/0
involves: 129P2/OlaHsd * FVB
abnormal amino acid level J:161082
abnormal ion homeostasis J:161082
abnormal postnatal growth J:161082
Glultm3Whla/Glultm3Whla
Tg(GFAP-cre)25Mes/0
involves: 129P2/OlaHsd * FVB/N
abnormal amino acid level J:162067
abnormal ammonia homeostasis J:162067
abnormal brain morphology J:162067
abnormal food intake J:162067
decreased circulating glucose level J:162067
decreased glutamine level J:162067
increased glycine level J:162067
postnatal lethality, complete penetrance J:162067

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory